Product image of Lacosamid 1 A Pharma (Lacosamide) supplied by GNH India

Lacosamid 1 A Pharma

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamid 1 A Pharma (Lacosamide)

Lacosamide, the active ingredient in Lacosamid 1 A Pharma, is a sodium channel blocker presented as an oral formulation for oral use. It is indicated for the treatment of partial‑onset seizures in patients with epilepsy.
GNH India supplies Lacosamid 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

1 A Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an anticonvulsant that acts on neuronal sodium channels to control seizure activity.

  • Partial‑onset (focal) seizures: Reduces seizure frequency when used as adjunctive therapy.
  • Adjunctive therapy for epilepsy: Improves overall seizure control when added to existing antiepileptic regimens.
  • Focal seizures in adults: Provides additional seizure reduction as part of a comprehensive treatment plan.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, which stabilizes hyperexcitable neuronal membranes and reduces the ability of neurons to fire repetitively, thereby diminishing seizure propagation.

Side Effects

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: A sensation of light‑headedness or unsteadiness.
  • Nausea: Mild to moderate stomach upset.
  • Fatigue: General feeling of tiredness.
  • Headache: Mild to moderate head pain.

Serious or Rare Side Effects

  • Cardiac conduction abnormalities: Prolongation of PR interval or arrhythmias.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Suicidal thoughts: Emergence or worsening of depressive symptoms.
  • Hypersensitivity: Rash, swelling, or anaphylactic reactions.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: Adjust dosing in patients with reduced kidney function.
  • Hepatic impairment: Use caution and monitor liver enzymes.
  • Cardiac conduction disorders: Obtain baseline ECG and monitor for PR‑interval changes.
  • Concomitant antiepileptic drugs: Assess for additive CNS depression.
  • Pregnancy: Use only if potential benefit justifies potential risk; data are limited.
  • Store at ambient temperature: Keep below 25 °C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lacosamide can interact with several drug classes; monitor patients accordingly.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase lacosamide plasma concentrations.
  • Strong CYP3A4 inducers (e.g., carbamazepine): May reduce therapeutic effect.
  • Other sodium‑channel blockers (e.g., phenytoin): Heightened risk of CNS depression.

Moderate Interactions (Monitor Closely)

  • Alcohol: May exacerbate dizziness and sedation.
  • Additional antiepileptic agents: May require dose adjustments.
  • SSRIs or SNRIs: Potential additive central nervous system effects.
  • Antihypertensives: May modestly affect blood pressure control.

Frequently Asked Questions

Lacosamid 1 A Pharma contains lacosamide, an anticonvulsant indicated for the treatment of partial‑onset (focal) seizures in patients with epilepsy, typically as an add‑on therapy to existing antiepileptic regimens.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neurons, which stabilizes hyperexcitable membranes and reduces the likelihood of repetitive neuronal firing that leads to seizures.

The specific dose and titration schedule are determined by the prescribing clinician based on the patient’s age, weight, renal function, and response to therapy. Patients should follow the prescriber’s instructions exactly.

Safety data for lacosamide in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and the decision should be made together with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation—differs from many traditional antiepileptics that block fast sodium channels. This can provide complementary seizure control when combined with other agents, and it is generally well tolerated, though individual response varies.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, excessive heat and direct sunlight to maintain stability and potency.

Lacosamid 1 A Pharma is taken orally, usually as a tablet, with or without food. The exact administration schedule should follow the prescriber’s guidance, and tablets should be swallowed whole with water.

Serious risks include cardiac conduction abnormalities such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and the emergence of suicidal thoughts or behaviors. Patients should be monitored for these events and seek immediate medical attention if they occur.

Patients with known hypersensitivity to lacosamide or any excipients, those with significant cardiac conduction disorders (e.g., second‑degree AV block) without appropriate monitoring, and individuals for whom the prescriber determines the risks outweigh the benefits should avoid using this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT